ASHG News

ASHG convened its Industry Roundtable in April 2026, bringing together Society leaders and representatives from companies across human genetics and genomics—including Illumina, BridgeBio, GeneDx, and PacBio. The Roundtable serves as a collaborative forum to discuss challenges and opportunities in the field, review progress on shared priorities, and identify new opportunities for partnership and investment that... Read More

Posted By: The American Journal of Human Genetics, AJHG AJHG: What motivated you to start working on this project?  NB: I think the topic of outliers is really interesting! At the start of my PhD, there were two ways I was thinking about outliers: people who have extreme observed values, and people who have extremely different... Read More

Posted By: The American Journal of Human Genetics, AJHG AJHG: What motivated you to start working on this project? XS: Alzheimer’s disease risk differs across populations, but much of the genetic and transcriptomic work in the field has historically focused on cohorts of European ancestry. That makes it harder to determine which disease-associated regulatory mechanisms are shared across... Read More

Posted By: HGG Advances HGGA: What motivated you to start working on this project? AT: With my PhD training in statistical genetics and genomics, I was eager to complement my discovery-focused training with functional genomics approaches during my postdoc. During this stage of my training, I’ve focused on using massively parallel reporter assays (MPRAs), which are used to measure... Read More

Posted By: HGG Advances HGGA: What motivated you to start working on this project? HC: This project came out of an ongoing collaboration with Wendy K. Chung, MD, PhD. We have been working together on a series of neurodevelopmental disease genes—her team handles patient ascertainment and genomic analysis, and our lab contributes Drosophila-based functional genomics. MARK2 was... Read More